Control of glioblastoma tumorigenesis by feed-forward cytokine signaling

Nature Neuroscience

Volumn 19, Issue 6, 2016, Pages 798-806

  Jahani As, Arezu ^a,b,c,d,e   Yin, Hang ^c,f,g   Soleimani, Vahab D ^d,e   Haque, Takrima ^d,e   Luchman, H Artee ^h   Chang, Natasha C ^c,f   Sincennes, Marie Claude ^c,f   Puram, Sidharth V ^a   Scott, Andrew M ⁱ   Lorimer, Ian A J ^c,f   Perkins, Theodore J ^c,f   Ligon, Keith L ^a   Weiss, Samuel ^h   Rudnicki, Michael A ^c,f   Bonni, Azad ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF GEORGIA   (United States)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOSTATIN M; ONCOSTATIN M RECEPTOR; RINDOPEPIMUT; STAT3 PROTEIN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR VIII;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CANCER CONTROL; CANCER STEM CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE REGULATORY NETWORK; GENE TARGETING; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; LIFESPAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MICE, TRANSGENIC; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84964270627     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4295     Document Type: Article

References (43)

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (2005).
2. Robins, H.I., Chang, S., Butowski, N. & Mehta, M. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr. Oncol. Rep. 9, 66-70 (2007).
3. Maher, E.A. et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311-1333 (2001).
4. Furnari, F.B. et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21, 2683-2710 (2007).
5. Wen, P.Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507 (2008).
6. Holland, E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2, 120-129 (2001).
7. Bachoo, R.M. et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1, 269-277 (2002).
8. Uhrbom, L. et al. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res. 62, 5551-5558 (2002).
9. Bajenaru, M.L. et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res. 63, 8573-8577 (2003).
10. Louis, D.N. Molecular pathology of malignant gliomas. Annu. Rev. Pathol. 1, 97-117 (2006).
11. Singh, S.K. et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63, 5821-5828 (2003).
12. Singh, S.K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
13. Galli, R. et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021 (2004).
14. Yuan, X. et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23, 9392-9400 (2004).
15. Wong, A.J. et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA 89, 2965-2969 (1992).
16. Nagane, M., Lin, H., Cavenee, W.K. & Huang, H.J. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett. 162, S17-S21 (2001).
17. de la Iglesia, N. et al. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev. 22, 449-462 (2008).
18. de la Iglesia, N., Puram, S.V. & Bonni, A. STAT3 regulation of glioblastoma pathogenesis. Curr. Mol. Med. 9, 580-590 (2009).
19. Mosley, B. et al. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271, 32635-32643 (1996).
20. Inda, M.M. et al. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 24, 1731-1745 (2010).
21. Fan, Q.W. et al. EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma. Cancer Cell 24, 438-449 (2013).
22. Biernat, W., Huang, H., Yokoo, H., Kleihues, P. & Ohgaki, H. Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol. 14, 131-136 (2004).
23. Zadeh, G., Bhat, K.P. & Aldape, K. EGFR and EGFRvIII in glioblastoma: partners in crime. Cancer Cell 24, 403-404 (2013).
24. de la Iglesia, N. et al. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J. Neurosci. 28, 5870-5878 (2008).
25. Bonni, A. et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477-483 (1997).
26. Jahani-Asl, A. & Bonni, A. iNOS: a potential therapeutic target for malignant glioma. Curr. Mol. Med. 13, 1241-1249 (2013).
27. Puram, S.V. et al. STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation. J. Neurosci. 32, 7806-7818 (2012).
28. Caffarel, M.M. & Coleman, N. Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. J. Pathol. 232, 386-390 (2014).
29. Winder, D.M. et al. Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness. J. Pathol. 225, 448-462 (2011).
30. Raz, R., Lee, C.K., Cannizzaro, L.A., d'Eustachio, P. & Levy, D.E. Essential role of STAT3 for embryonic stem cell pluripotency. Proc. Natl. Acad. Sci. USA 96, 2846-2851 (1999).
31. Kelly, J.J. et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 27, 1722-1733 (2009).
32. Luchman, H.A. et al. An in vivo patient-derived model of endogenous IDH1-mutant glioma. Neuro. Oncol. 14, 184-191 (2012).
33. Di Giorgio, F.P., Carrasco, M.A., Siao, M.C., Maniatis, T. & Eggan, K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10, 608-614 (2007).
34. Nagai, M. et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 10, 615-622 (2007).
35. Bryant, D.M. et al. A molecular network for de novo generation of the apical surface and lumen. Nat. Cell Biol. 12, 1035-1045 (2010).
36. Huang, W., Sherman, B.T. & Lempicki, R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
37. Soleimani, V.D., Palidwor, G.A., Ramachandran, P., Perkins, T.J. & Rudnicki, M.A. Chromatin tandem affinity purification sequencing. Nat. Protoc. 8, 1525-1534 (2013).
38. Soleimani, V.D. et al. Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs. Dev. Cell 22, 1208-1220 (2012).
39. Soleimani, V.D. et al. Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis. Mol. Cell 47, 457-468 (2012).
40. Bailey, T.L., Williams, N., Misleh, C. & Li, W.W. MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic Acids Res. 34, W369-W373 (2006).
41. Grant, C.E., Bailey, T.L. & Noble, W.S. FIMO: scanning for occurrences of a given motif. Bioinformatics 27, 1017-1018 (2011).
42. Bewick, V., Cheek, L. & Ball, J. Statistics review 12: survival analysis. Crit. Care 8, 389-394 (2004).
43. Lavictoire, S.J., Parolin, D.A., Klimowicz, A.C., Kelly, J.F. & Lorimer, I.A. Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII. J. Biol. Chem. 278, 5292-5299 (2003).